C2 and cancer: However, the presence of HLA C2-ligands was associated with a higher frequency of KIR2DL1+ NK cells (8.88 vs. 4.23, p < 0.01) (Figure 3B), a difference that persisted in all groups of cancer patients regardless of whether they survived or succumbed to the disease during follow-up (Figure 3C).